ADRB2 Genotyping for Beta-2 Agonist Responsiveness Test sale cost 960 AED
Everolimus Test sale cost 1020 AED Everolimus Test Cost 1,200 د.إ Original price was: 1,200 د.إ.1,020 د.إCurrent price is: 1,020 د.إ.
Tacrolimus FK506 Test sale cost 840 AED Tacrolimus FK506 Test Cost 940 د.إ Original price was: 940 د.إ.840 د.إCurrent price is: 840 د.إ.
Sale!

ADRB2 Genotyping for Beta-2 Agonist Responsiveness Test Cost

Original price was: 1,060 د.إ.Current price is: 960 د.إ.

-9%

The ADRB2 Genotyping for Beta-2 Agonist Responsiveness Test is a cutting-edge diagnostic procedure designed to evaluate an individual’s genetic predisposition towards the efficacy of beta-2 agonist medications. This test specifically targets the ADRB2 gene, which encodes the beta-2 adrenergic receptor. Variations in this gene can significantly influence an individual’s response to beta-2 agonists, a class of drugs commonly used in the treatment of asthma and other respiratory conditions. By analyzing the genetic makeup of the ADRB2 gene, healthcare providers can tailor medication plans to better suit the genetic profile of their patients, potentially enhancing drug efficacy and minimizing side effects.

Performed at DNA Labs UAE, a leading facility in genetic testing, the ADRB2 Genotyping for Beta-2 Agonist Responsiveness Test is priced at 960 AED. The lab utilizes state-of-the-art technology to ensure accurate and reliable results, providing valuable insights into personalized medicine. This test represents a significant step forward in the field of pharmacogenomics, offering a more individualized approach to the management of respiratory conditions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ADRB2 Genotyping for Beta-2 Agonist Responsiveness Test

Test Cost: AED 960.0

Symptoms Diagnosis: No Special preparation required

Test Name: ADRB2 Genotyping for Beta-2 Agonist Responsiveness

Test Components: PCR Sequencing

Price: 960.0 AED

Sample Condition: 4 mL (2 mL min.) whole Blood in 1 Lavender top (EDTA) Tube. Ship refrigerated. DO NOT FREEZE.

Report Delivery: SampleSat by 11 am; Report 10 Working days

Method: PCR Sequencing

Test Type: Pharmacogenomics

Doctor: Physician

Test Department: Molecular Diagnostics

Pre Test Information: No Special preparation required

What is ADRB2 Genotyping for Beta-2 Agonist Responsiveness?

ADRB2 genotyping for beta-2 agonist responsiveness is a genetic test that examines variations in the ADRB2 gene, which codes for the beta-2 adrenergic receptor. This receptor is the target for beta-2 agonist medications, such as albuterol, which are commonly used to treat asthma and other respiratory conditions.

The purpose of this test is to identify specific variations in the ADRB2 gene that may impact an individual’s response to beta-2 agonist medications. Some genetic variations in this gene have been associated with increased or decreased responsiveness to these medications.

By identifying these genetic variations, healthcare providers can personalize treatment plans for individuals with respiratory conditions. This can help optimize medication selection and dosing, leading to better symptom control and improved overall health outcomes.

How is the Test Performed?

The test is typically performed using a sample of DNA, which can be obtained from a blood sample or a cheek swab. The DNA is then analyzed to identify any variations in the ADRB2 gene.

It is important to note that while this test can provide valuable information, it is just one factor to consider when determining the most appropriate treatment plan. Other factors, such as an individual’s medical history, symptoms, and other genetic variations, should also be taken into account.

Conclusion

ADRB2 genotyping for beta-2 agonist responsiveness is a useful tool for personalized medicine in the treatment of respiratory conditions. It can help healthcare providers make more informed decisions about medication selection and dosing, leading to improved outcomes for individuals with these conditions.

Test Name ADRB2 GENOTYPING FOR BETA-2 AGONIST RESPONSIVENESS Test
Components
Price 960.0 AED
Sample Condition 4 mL (2 mL min.) whole Blood in 1 Lavender top (EDTA) Tube. Ship refrigerated. DO NOT FREEZE.
Report Delivery SampleSat by 11 am;Report 10 Working days
Method PCR Sequencing
Test type Pharmacogenomics
Doctor Physician
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information No Special preparation required
Test Details

ADRB2 genotyping for beta-2 agonist responsiveness is a genetic test that examines variations in the ADRB2 gene, which codes for the beta-2 adrenergic receptor. This receptor is the target for beta-2 agonist medications, such as albuterol, which are commonly used to treat asthma and other respiratory conditions.

The purpose of this test is to identify specific variations in the ADRB2 gene that may impact an individual’s response to beta-2 agonist medications. Some genetic variations in this gene have been associated with increased or decreased responsiveness to these medications.

By identifying these genetic variations, healthcare providers can personalize treatment plans for individuals with respiratory conditions. This can help optimize medication selection and dosing, leading to better symptom control and improved overall health outcomes.

The test is typically performed using a sample of DNA, which can be obtained from a blood sample or a cheek swab. The DNA is then analyzed to identify any variations in the ADRB2 gene.

It is important to note that while this test can provide valuable information, it is just one factor to consider when determining the most appropriate treatment plan. Other factors, such as an individual’s medical history, symptoms, and other genetic variations, should also be taken into account.

Overall, ADRB2 genotyping for beta-2 agonist responsiveness is a useful tool for personalized medicine in the treatment of respiratory conditions. It can help healthcare providers make more informed decisions about medication selection and dosing, leading to improved outcomes for individuals with these conditions.

SKU: TEST-5876 Category:

Related products